Landing, NJ, United States of America

Kenneth Pennline

This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Pennline. Retrieved from https://idiyas.com/inventor/kenneth-pennline

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Pennline: Innovator in Diabetes Treatment

Introduction

Kenneth Pennline is a notable inventor based in Landing, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of insulin-dependent diabetes mellitus. His innovative approach has led to the development of a patented method that aims to improve the lives of those affected by this condition.

Latest Patents

Kenneth holds 1 patent for his work titled "Methods of treating insulin-dependent diabetes mellitus." This patent reflects his dedication to advancing medical treatments and enhancing patient care.

Career Highlights

Kenneth is currently employed at Schering Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His role at the company allows him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Throughout his career, Kenneth has worked alongside esteemed colleagues such as Martha W Bond and Paulo J Vieira. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of excellence in their respective fields.

Conclusion

Kenneth Pennline's contributions to diabetes treatment exemplify the impact of innovation in healthcare. His work not only highlights his expertise but also underscores the importance of collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…